- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01966835
Effect of Moderate to High Intensity Aerobic Interval Training on Polysomnographic Measured Sleep in Patients With Rheumatoid Arthritis (JR)
Effect of Moderate to High Intensity Aerobic Interval Training on Polysomnographic Measured Sleep in Patients With Rheumatoid Arthritis. A Randomized Controlled Trial
Poor sleep quality and sleep disturbances are common in patients with rheumatoid arthritis and are associated with an increased risk of co-morbidity and all-cause mortality.Few studies have examined the possibilities of improving sleep in patients with rheumatoid arthritis, and the focus has primarily been on medical treatment. Aerobic exercise training constitutes a potentially promising, non-pharmacological alternative to improve sleep.
This study is a randomized controlled trial of 44 patients with rheumatoid arthritis.
The aim is to investigate the effect of a moderate-to-high intensity aerobic interval training intervention on sleep quality and sleep disturbances in patients with rheumatoid arthritis.
The primary hypothesis is that moderate-to high intensity aerobic exercise will improve objective measured sleep quality and sleep disturbances. The secondary hypothesis is that the intervention may improve fitness, subjective sleep quality and physical function as well as reduce pain, fatigue, depressive symptoms and improve health-related quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Poor sleep quality and sleep disturbances are common in patients with rheumatoid arthritis and are associated with an increased risk of co-morbidity, including cardiovascular diseases, diabetes, hypertension, and all-cause mortality. In addition, poor sleep quality is associated with fatigue, pain and physical disability. Few studies have examined the possibilities of improving sleep in patients with rheumatoid arthritis, and the focus has primarily been on medical treatment. Aerobic exercise training constitutes a potentially promising, non-pharmacological alternative to improve sleep in healthy people and patients with insomnia.
The present study is a blinded randomized controlled trial of 44 patients with a diagnosis of rheumatoid arthritis.
The aim is to examine the effect of an aerobic exercise intervention, consisting of 18 exercise sessions, on sleep quality and sleep disturbances in patients with rheumatoid arthritis who experience poor sleep quality.
The primary hypothesis is that moderate to high intensity aerobic exercise will improve objective measured (by polysomnography) sleep quality and sleep disturbances. The secondary hypothesis is that the intervention may improve fitness, subjective sleep quality and physical function as well as reduce pain, fatigue, depressive symptoms and improve health-related quality of life.
The study will provide evidence on the effect of moderate-to-high-intensity aerobic exercise on the improvement of sleep in patients with rheumatoid arthritis. Specifically, the results are expected to provide important evidence about the potential of interval training to improve quality of sleep and sleep disturbances. As such, the study meets a currently unmet need for non-pharmacological treatment initiatives of poor sleep in patients with a systemic inflammatory disorder.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Copenhagen
-
Glostrup, Copenhagen, Denmark, 2600
- Recruiting
- Glostrup Hospital, Copenhagen University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 18-70 years
- a clinical diagnosis of rheumatoid arthritis
- Experience poor sleep quality (PSQI >5)
- Low disease activity (DAS28<3.2)
- Understand Danish
Exclusion Criteria:
- Documented sleep apnea (AHI >15/hour)
- ECG that does not allow exercise
- Night work during the period in which the intervention takes place
- Pregnant or are breast-feeding
- Treatment with steroid, hypnotics, antidepressants, antipsychotics
- Cardiac symptoms - NYHA >2
- Regular physically active (aerobic exercise >3 x per week)
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High intensity aerobic interval training
The intervention consists of a total of 18 moderate-to-high intensity aerobic interval training sessions (20-30 minutes/session) spread over a maximum of eight weeks (2-3 times/week) as shown in Table 1.
The training sessions are performed on bicycle ergometers (Kettler) and supervised by physiotherapists.
Each session is built up by brief periods of high-intensity aerobic exercise (70-80 %) separated by recovery periods of lower-intensity (40-50%).
Each session is introduced by a 5-minute warm-up and ends with a 5-minute cool-down (equivalent to 40-50% watt max).
The absolute exercise intensity/workload (watt) is determined individually for each participant based on the watt max test performed at baseline.
|
The intervention consists of a total of 18 moderate-to-high intensity aerobic interval training sessions (20-30 minutes/session) spread over a maximum of eight weeks (2-3 times/week) as shown in Table 1.
The training sessions are performed on bicycle ergometers (Kettler) and supervised by physiotherapists.
Each session is built up by brief periods of high-intensity aerobic exercise (70-80 %) separated by recovery periods of lower-intensity (40-50%).
Each session is introduced by a 5-minute warm-up and ends with a 5-minute cool-down (equivalent to 40-50% watt max).
The absolute exercise intensity/workload (watt) is determined individually for each participant based on the watt max test performed at baseline.
|
|
No Intervention: control group
no exercise intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sleep
Time Frame: Change from baseline in objectively measured sleep to 8 weeks
|
Measured by polysomnography.
Polysomnography is a objective measurement of sleep duration, sleep stages and sleep quality.
|
Change from baseline in objectively measured sleep to 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiopulmonary fitness
Time Frame: change in baseline in VO2-max to 8 weeks
|
The patients' aerobic capacity is assessed by an incremental maximum work test on bicycle ergometer.
Following a 5-minute warm-up period on individual steady state work intensity, the work load increases by 20 watt each minute until exhaustion.
|
change in baseline in VO2-max to 8 weeks
|
|
Plasma
Time Frame: change from baseline in plasma to 8 weeks
|
C-reactive protein (CRP) and hemoglobin are assessed
|
change from baseline in plasma to 8 weeks
|
|
physiological outcomes
Time Frame: change from baseline in blood pressure, weight and height to 8 weeks
|
change from baseline in blood pressure, weight and height to 8 weeks
|
|
|
Disease activity
Time Frame: change from baseline in disease activity to 8 weeks
|
Disease Activity Score (DAS28) is calculated from the number of swollen and tender joints (28 joints), CRP and the patients' global assessment of arthritis
|
change from baseline in disease activity to 8 weeks
|
|
self reported sleep quality and sleep disturbances
Time Frame: change from baseline in selfreported sleep to 8 weeks
|
The Pittsburgh Sleep Quality Index (PSQI) measures self-reported sleep quality and disturbances during the previous four weeks
|
change from baseline in selfreported sleep to 8 weeks
|
|
self reported sleepiness
Time Frame: change from baseline in sleepiness to 8 weeks
|
The Epworth Sleepiness Scale measures self-reported daytime sleepiness.
|
change from baseline in sleepiness to 8 weeks
|
|
self reported fatigue
Time Frame: change from baseline in fatigue to 8 weeks
|
The Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ)measures self-reported fatigue
|
change from baseline in fatigue to 8 weeks
|
|
self reported depressive symptoms
Time Frame: change from baseline in depressive symptoms to 8 weeks
|
The Center for Epidemiological Studies-Depression (CES-D) measures self-reported depressive symptoms.
|
change from baseline in depressive symptoms to 8 weeks
|
|
Physical function
Time Frame: change from baseline in HAQ score to 8 weeks
|
The Health Assessment Questionnaire (HAQ) measures self-reported physical function.
|
change from baseline in HAQ score to 8 weeks
|
|
self reported Health-related quality of life
Time Frame: change from baseline in health related quality of life to 8 weeks
|
EuroQol (EQ-5D-5L)measures health-related quality of life.
|
change from baseline in health related quality of life to 8 weeks
|
|
Health and lifestyle questionnaire
Time Frame: change from baseline in health and lifestyle to 8 weeks
|
Information about self-reported comorbidity, age, gender, education, work, income, physical activity, smoking, alcohol and caffeinated drinks per day will be recorded.
Patients are also asked of information about actual medical treatment.
|
change from baseline in health and lifestyle to 8 weeks
|
|
Sleep pattern
Time Frame: change from baseline to 8 weeks
|
Patients complete sleep diaries for 14 days after each polysomnography measurement in order to closely and prospectively monitor and describe potential changes in their sleep.
|
change from baseline to 8 weeks
|
Collaborators and Investigators
Investigators
- Study Director: Poul Jennum, Professor, Danish center for sleep medicine, department of clinical neurophysiology, Glostrup Hospital, Copenhagen University, Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- JR sleep
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
Yuanyuan ZhangRecruitingRheumatoid Arthritis (RA) | Rheumatoid Arthritis-Associated Interstitial Lung Disease | Difficult-to-Treat Rheumatoid ArthritisChina
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Richard Burt, MDTerminated
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
University Hospital, ToulouseCompletedRheumatoId ArthritisFrance
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
Clinical Trials on High intensity aerobic interval training
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
University of Texas, El PasoEnrolling by invitation
-
University of ValenciaEuropean Regional Development Fund; Ministerio de Ciencia e Innovación, Spain; Universitat Politècnica de València and other collaboratorsCompletedDiabetes Mellitus, Type 1Spain
-
Norwegian University of Science and TechnologyCompleted
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Education University of Hong KongCompleted
-
University of AlbertaCompleted
-
Riphah International UniversityCompleted